Pages that link to "Q114434866"
Jump to navigation
Jump to search
The following pages link to Gary A Noskin (Q114434866):
Displaying 50 items.
- Chicago Ebola Response Network (CERN): A Citywide Cross-hospital Collaborative for Infectious Disease Preparedness (Q28080808) (← links)
- The impact of infection control upon hospital-acquired influenza and respiratory syncytial virus (Q30423023) (← links)
- Utility of commonly captured data from an EHR to identify hospitalized patients at risk for clinical deterioration. (Q31170823) (← links)
- Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones (Q31356619) (← links)
- Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984. (Q31617171) (← links)
- Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data. (Q31998538) (← links)
- Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data (Q33424813) (← links)
- Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center. (Q33691981) (← links)
- Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission (Q33790986) (← links)
- Paenibacillus macerans pseudobacteremia resulting from contaminated blood culture bottles in a neonatal intensive care unit (Q33941470) (← links)
- Contamination of the clinical microbiology laboratory with vancomycin-resistant enterococci and multidrug- resistant Enterobacteriaceae: implications for hospital and laboratory workers (Q33973793) (← links)
- In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci (Q33977497) (← links)
- Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci (Q33982606) (← links)
- The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance (Q34057042) (← links)
- New technology for detecting multidrug-resistant pathogens in the clinical microbiology laboratory (Q34213735) (← links)
- Engineering infection control through facility design (Q34213761) (← links)
- The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database (Q34441366) (← links)
- Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients (Q34727621) (← links)
- Microbiologic surveillance using nasal cultures alone is sufficient for detection of methicillin-resistant Staphylococcus aureus isolates in neonates (Q35027446) (← links)
- Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay. (Q35091494) (← links)
- Native valve endocarditis due to a novel strain of Legionella (Q35192169) (← links)
- Enhanced identification of postoperative infections among inpatients (Q35896011) (← links)
- Tigecycline: a new glycylcycline for treatment of serious infections (Q36218312) (← links)
- Efficacy and safety of scheduled dosing of opioid analgesics: a quality improvement study (Q36276083) (← links)
- Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia (Q36428418) (← links)
- Initial use of a broth microdilution method suitable for in vitro testing of fungal isolates in a clinical microbiology laboratory (Q36523393) (← links)
- Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens (Q36523688) (← links)
- Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates. (Q36537538) (← links)
- Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans (Q36544546) (← links)
- Postpartum mastitis and community-acquired methicillin-resistant Staphylococcus aureus (Q37302717) (← links)
- Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis (Q37388301) (← links)
- Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review (Q37577833) (← links)
- Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention (Q37993717) (← links)
- Comparison of the Rodac imprint method to selective enrichment broth for recovery of vancomycin-resistant enterococci and drug-resistant Enterobacteriaceae from environmental surfaces. (Q39462681) (← links)
- Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program (Q39463844) (← links)
- Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae. (Q39465570) (← links)
- Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones (Q39471518) (← links)
- A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux. (Q39473327) (← links)
- Comparison of an automated ribotyping system to restriction endonuclease analysis and pulsed-field gel electrophoresis for differentiating vancomycin-resistant Enterococcus faecium isolates (Q39665254) (← links)
- Incidence and types of non-ideal care events in an emergency department (Q39946805) (← links)
- Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual (Q40179593) (← links)
- In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii (Q40241381) (← links)
- Peritoneal fluid penetration of tigecycline (Q40278338) (← links)
- Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement (Q40352231) (← links)
- Computer-assisted surveillance for detecting clonal outbreaks of nosocomial infection (Q40526903) (← links)
- Fever and neutropenia clinical practice guidelines. (Q40527041) (← links)
- Respiratory syncytial virus outbreak on an adult stem cell transplant unit (Q40608980) (← links)
- Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome (Q40689196) (← links)
- Association Between Hospital Characteristics and Performance on the New Hospital-Acquired Condition Reduction Program's Surgical Site Infection Measures (Q40726428) (← links)
- Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). (Q40771664) (← links)